BetterScholar BetterScholar

G. Lazennec

Molecular Endocrinology, Trends in Molecular Medicine, Endocrine-Related Cancer, Endocrinology, Breast Cancer Research, Stem Cells, Oncogene, Recent Progress in Hormone Research Show more
11
Role
Title
Level Year L/R
🦁 Chemokines and chemokine receptors: new insights into cancer-related inflammation.
G. Lazennec, A. Richmond 		9 2010
9
🦁
🐬 Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.
Allison Bardin, N. Boulle, G. Lazennec, F. Vignon, P. Pujol 		8 2004
8
🐬
🦁 ERβ Inhibits Proliferation and Invasion of Breast Cancer Cells.
G. Lazennec, D. Bresson, A. Lucas, C. Chauveau, F. Vignon 		8 2001
8
🦁
🐒 Oestrogen receptor negative breast cancers exhibit high cytokine content
8 auth. Carine Chavey, F. Bibeau, S. Gourgou-Bourgade, Sandrine Burlinchon, F. Boissiere, D. Laune, ... S. Roques, G. Lazennec 		8 2007
8
🐒
🐬 RelB, a new partner of aryl hydrocarbon receptor-mediated transcription.
Christoph F. A. Vogel, Eric M. Sciullo, Wen Li, Pat Wong, G. Lazennec, Fumio Matsumura 		8 2007
8
🐬
🦁 Concise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit?
G. Lazennec, C. Jorgensen 		7 2008
7
🦁
🐬 Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
Karen E. Weis, K. Ekena, James A. Thomas, G. Lazennec, B. Katzenellenbogen 		7 1996
7
🐬
🐒 IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells
8 auth. Ariane Freund, C. Chauveau, J. Brouillet, A. Lucas, M. Lacroix, A. Licznar, ... F. Vignon, G. Lazennec 		7 2003
7
🐒
🦁 Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.
G. Lazennec, G. Lazennec, L. Canaple, D. Saugy, W. Wahli 		7 2000
7
🦁
🦁 Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.
G. Lazennec, G. Lazennec, L. Canaple, D. Saugy, W. Wahli 		7 2000
7
🦁
🐜 Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
16 auth. B. Katzenellenbogen, M. M. Montano, T. R. Ediger, Jun Sun, K. Ekena, G. Lazennec, Paolo G. V. Martini, E. McInerney, RΓ©gis Delage-Mourroux, Karen E. Weis, ... J. Katzenellenbogen, Susan C. Nagel, W. Schrader, C. Bethea, G. Cutler, J. Hock 		7 2000
7
🐜